A phase 3 trial finds pritelivir significantly improves cure rates for immunocompromised individuals with refractory HSV infections.
Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management ROATAN, BAY ...
Researchers at the University of Jyväskylä (Finland), in cooperation with national and international research groups, have ...
Viruses are entirely dependent on their hosts to reproduce. They ransack living cells for parts and energy and hijack the host's cellular machinery to make new copies of themselves. Herpes simplex ...
Clinical Trials Arena on MSN
AiCuris reports positive Phase III pritelivir results for HSV patients
The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.
All organisms — from fungi to mammals — have the capacity to evolve and adapt to their environments. But viruses are master shapeshifters with an ability to mutate greater than any other organism. As ...
A combination of anti-inflammatory and antiviral agents could improve treatment of encephalitis caused by herpes simplex virus-1 (HSV-1), according to new research utilizing cerebral organoids. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results